Eli Lilly and Company Analysis
| Analyst Ratings |
|
Average Target Price
|
389.30
|
|
Average Rating
|
4.13
|
|
# Strong Buys
|
11
|
|
# Buys
|
6
|
|
# Holds
|
6
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
1.92
|
1.98
|
0.06
|
3.13%
|
|
2022-06-30
|
1.69
|
1.25
|
-0.44
|
-26.04%
|
|
2022-03-31
|
2.32
|
2.62
|
0.30
|
12.93%
|
|
2021-12-31
|
2.46
|
2.49
|
0.03
|
1.22%
|
|
2021-09-30
|
1.98
|
1.94
|
-0.04
|
-2.02%
|
|
2021-06-30
|
1.89
|
1.87
|
-0.02
|
-1.06%
|
|
2021-03-31
|
2.13
|
1.87
|
-0.26
|
-12.21%
|
|
2020-12-31
|
2.35
|
2.75
|
0.40
|
17.02%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
5.85
|
|
2021-12-31
|
8.17
|
|
2020-12-31
|
7.93
|
|
2019-12-31
|
6.04
|
|
2018-12-31
|
5.56
|
|
2017-12-31
|
4.28
|
|
2016-12-31
|
3.52
|
|
2015-12-31
|
3.44
|
|
2014-12-31
|
2.79
|
|
2013-12-31
|
4.15
|
|
2012-12-31
|
3.39
|
|
2011-12-31
|
4.42
|
|
2010-12-31
|
4.74
|
|
2009-12-31
|
4.43
|
|
2008-12-31
|
4.02
|
|
2007-12-31
|
3.55
|
|
2006-12-31
|
3.18
|
|
2005-12-31
|
2.88
|
|
2004-12-31
|
2.82
|
|
2003-12-31
|
2.58
|
|
2002-12-31
|
2.55
|
|
2001-12-31
|
2.76
|
|
2000-12-31
|
2.65
|
|
1999-12-31
|
2.28
|
|
1998-12-31
|
1.95
|
|
1997-12-31
|
1.61
|
|
1996-12-31
|
1.40
|